Core Points - The total number of shares released from restrictions is 1,620,000, accounting for 1.4547% of the company's total share capital, with the trading date set for September 2, 2025 [1] - The reasons for the release of restrictions include annual releases for directors, supervisors, and senior management, as well as voluntary releases and other specific reasons [1] - After the release of restrictions, the total share capital of the company will be 111,360,400 shares, with 70,630,900 shares (63.4255%) being unrestricted and 40,729,500 shares (36.5745%) being restricted [1] Detailed Summary - The company guarantees the authenticity, accuracy, and completeness of the announcement content, taking legal responsibility for any misrepresentation or omissions [1] - The details of the restricted shares include that there are no outstanding commitments from the shareholders applying for the release, and there are no non-operational fund occupation situations concerning the company [2] - The company confirms that there are no violations or damages to the company's interests related to the shareholders applying for the release of restrictions [2]
大禹生物: 股票解除限售公告